Cargando…
Convalescent plasma from people vaccinated after COVID-19 infection
Autores principales: | Jabal, Kamal Abu, Wiegler, Karine Beiruti, Edelstein, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987300/ https://www.ncbi.nlm.nih.gov/pubmed/33778791 http://dx.doi.org/10.1016/S2666-5247(21)00060-4 |
Ejemplares similares
-
Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel
por: Kuodi, Paul, et al.
Publicado: (2022) -
SARS-CoV-2 immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January–March 2021
por: Abu Jabal, Kamal, et al.
Publicado: (2021) -
Association between BNT162b2 vaccination and health-related quality of life up to 18 months post-SARS-CoV-2 infection in Israel
por: Kuodi, Paul, et al.
Publicado: (2023) -
Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021
por: Abu Jabal, Kamal, et al.
Publicado: (2021) -
Antibody-Mediated Immunogenicity Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Following Priming, Boosting, and Hybrid Immunity: Insights From 11 Months of Follow-up of a Healthcare Worker Cohort in Israel, December 2020–October 2021
por: Edelstein, Michael, et al.
Publicado: (2022)